These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23137509)

  • 1. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
    Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life.
    Mann I; Rodrigo SF; van Ramshorst J; Beeres SL; Dibbets-Schneider P; de Roos A; Wolterbeek R; Zwaginga JJ; Fibbe WE; Bax JJ; Schalij MJ; Atsma DE
    Circ Cardiovasc Interv; 2015 Aug; 8(8):. PubMed ID: 26259770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.
    Rodrigo SF; van Ramshorst J; Mann I; Leong DP; Cannegieter SC; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Bax JJ; Schalij MJ; Beeres SL; Atsma DE
    Int J Cardiol; 2014 Aug; 175(3):539-44. PubMed ID: 25023791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia.
    Beeres SL; Lamb HJ; Roes SD; Holman ER; Kaandorp TA; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Bax JJ; Atsma DE
    J Magn Reson Imaging; 2008 May; 27(5):992-7. PubMed ID: 18425845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am Heart J; 2006 Oct; 152(4):684.e11-6. PubMed ID: 16996834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
    Gyöngyösi M; Khorsand A; Zamini S; Sperker W; Strehblow C; Kastrup J; Jorgensen E; Hesse B; Tägil K; Bøtker HE; Ruzyllo W; Teresiñska A; Dudek D; Hubalewska A; Rück A; Nielsen SS; Graf S; Mundigler G; Novak J; Sochor H; Maurer G; Glogar D; Sylven C
    Circulation; 2005 Aug; 112(9 Suppl):I157-65. PubMed ID: 16159809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.
    Charwat S; Lang I; Dettke M; Graf S; Nyolczas N; Hemetsberger R; Zamini S; Khorsand A; Sochor H; Maurer G; Glogar D; Gyöngyösi M
    Thromb Haemost; 2010 Mar; 103(3):564-71. PubMed ID: 20076851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.
    Briguori C; Reimers B; Sarais C; Napodano M; Pascotto P; Azzarello G; Bregni M; Porcellini A; Vinante O; Zanco P; Peschle C; Condorelli G; Colombo A
    Am Heart J; 2006 Mar; 151(3):674-80. PubMed ID: 16504630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of intracoronary stem cell therapy after acute myocardial infarction.
    Wöhrle J; Merkle N; Mailänder V; Nusser T; Schauwecker P; von Scheidt F; Schwarz K; Bommer M; Wiesneth M; Schrezenmeier H; Hombach V
    Am J Cardiol; 2010 Mar; 105(6):804-12. PubMed ID: 20211323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia.
    Beeres SL; Bax JJ; Roes SD; Lamb HJ; Fibbe WE; De Roos A; Van Der Wall EE; Schalij MJ; Atsma DE
    Acute Card Care; 2007; 9(4):243-51. PubMed ID: 17926149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Transendocardial Delivery of Bone Marrow-Derived CD133
    Wojakowski W; Jadczyk T; Michalewska-Włudarczyk A; Parma Z; Markiewicz M; Rychlik W; Kostkiewicz M; Gruszczyńska K; Błach A; Dzier Zak-Mietła M; Wańha W; Ciosek J; Ochała B; Rzeszutko Ł; Cybulski W; Partyka Ł; Zasada W; Włudarczyk W; Dworowy S; Kuczmik W; Smolka G; Pawłowski T; Ochała A; Tendera M
    Circ Res; 2017 Feb; 120(4):670-680. PubMed ID: 27903568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
    Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.